# Statistical Results (CSV Files)

This directory contains all statistical output files generated by the analysis scripts. Every statistic reported in the manuscript can be traced to one of these files. The [`CHECKER_REPORT.md`](../../CHECKER_REPORT.md) documents the stat-by-stat verification.

---

## Primary Analysis Outputs

### `tcga_multicancer_correlations.csv`
**Generated by:** `scripts/tcga_multicancer.py`
**Description:** Spearman correlation results for all gene-pair comparisons across six TCGA cohorts.
**Rows:** 102 (17 comparisons x 6 cohorts)
**Key columns:** cohort, gene_pair, rho, p_value, q_value, n
**Manuscript reference:** Results 3.1, Table 1

### `tumor_normal_comparison.csv`
**Generated by:** `scripts/tcga_tumor_normal.py`
**Description:** Tumor vs matched normal circadian CV comparisons using Wilcoxon signed-rank and Mann-Whitney U tests.
**Rows:** ~35
**Manuscript reference:** Results 3.4

### `immune_subtype_comparison.csv`
**Generated by:** `scripts/tcga_immune_subtype.py`
**Description:** AM/DC/Mixed subtype prevalence and circadian CV statistics (Kruskal-Wallis, Mann-Whitney) across six cohorts.
**Rows:** 6 (one per cohort)
**Manuscript reference:** Results 3.5

### `survival_logrank_results.csv`
**Generated by:** `scripts/tcga_survival.py`
**Description:** Log-rank test results for all 12 pre-specified survival contrasts (6 AM-vs-DC + 6 Q1-vs-Q4) with Benjamini-Hochberg FDR correction.
**Rows:** 12
**Key columns:** cohort, test, p_value, q_value, category (FDR-significant / Nominal / Non-significant)
**Manuscript reference:** Results 3.6, Evidence Summary Table

### `stage_analysis_results.csv`
**Generated by:** `scripts/tcga_stage_analysis.py`
**Description:** Stage-stratified circadian CV analysis (Kruskal-Wallis, Spearman trend) across six cohorts.
**Rows:** ~48
**Manuscript reference:** Results 3.8

### `master_fdr_results.csv`
**Generated by:** `scripts/tcga_stage_analysis.py`
**Description:** Global Benjamini-Hochberg FDR correction across all 244+ statistical tests in the study.
**Rows:** 244
**Manuscript reference:** Results 3.8 (global FDR context)

---

## Sensitivity Analysis Outputs

### `robustness_primary_tests.csv`
**Generated by:** `scripts/robustness_check.py`
**Description:** Hazard ratios from 8 multivariable Cox PH models (SKCM + LUAD), including adjusted AM-vs-DC, PD-L1/B2M-controlled, and interaction terms.
**Rows:** 8
**Key columns:** cohort, model, HR, p_value, q_value
**Manuscript reference:** Results 3.7, Evidence Summary Table

### `robustness_cox_coefficients.csv`
**Generated by:** `scripts/robustness_check.py`
**Description:** Full coefficient tables from all Cox models (all covariates, not just boundary-mode terms).
**Rows:** ~200
**Manuscript reference:** Supplementary material

### `robustness_partial_correlations.csv`
**Generated by:** `scripts/robustness_check.py`
**Description:** Partial correlations between circadian CV and PD-L1 after adjusting for clinical and immune covariates.
**Rows:** ~10
**Manuscript reference:** Results 3.7

### `robustness_ph_diagnostics.csv`
**Generated by:** `scripts/robustness_check.py`
**Description:** Proportional hazards assumption diagnostics (Schoenfeld residual tests) for all Cox models.
**Rows:** ~200 (one per covariate per model)
**Manuscript reference:** Limitations

### `rmst_results.csv`
**Generated by:** `scripts/sensitivity_rmst.py`
**Description:** Restricted Mean Survival Time differences (AM minus DC) at 4 time horizons (36, 60, 84, 120 months) with bootstrap 95% CIs.
**Rows:** 8 (2 cohorts x 4 horizons)
**Key columns:** cohort, tau, rmst_diff, ci_lower, ci_upper
**Manuscript reference:** Results 3.7

### `threshold_sensitivity_results.csv`
**Generated by:** `scripts/sensitivity_threshold_sweep.py`
**Description:** Log-rank survival test results at each AM/DC threshold percentile (25th to 75th, step 5).
**Rows:** 22 (11 thresholds x 2 cohorts)
**Manuscript reference:** Results 3.6

### `immune_residualization_results.csv`
**Generated by:** `scripts/sensitivity_immune_residualization.py`
**Description:** CV-PD-L1 correlations after OLS residualization on immune covariates, plus purity-stratified results.
**Rows:** ~16
**Manuscript reference:** Results 3.9

### `observability_index_results.csv`
**Generated by:** `scripts/composite_observability_index.py`
**Description:** Independent observability index results using features orthogonal to AM/DC classification.
**Rows:** 6 (one per cohort)
**Manuscript reference:** Results 3.10

---

## External Validation Outputs

### `external_validation_results.csv`
**Generated by:** `scripts/run_external_validation.py`
**Description:** CV-PD-L1 Spearman correlation and AM/DC response comparison in GSE91061 (nivolumab melanoma, n=49).
**Manuscript reference:** Results 3.11

### `external_validation_gse78220.csv`
**Generated by:** `scripts/external_validation_gse78220.py`
**Description:** CV-PD-L1 correlation in GSE78220 (anti-PD-1 melanoma, n=27).
**Manuscript reference:** Results 3.11

### `external_validation_gse115821.csv`
**Generated by:** `scripts/external_validation_gse136961.py`
**Description:** CV-PD-L1 correlation in GSE115821 (melanoma, n=37).
**Manuscript reference:** Results 3.11

---

## Convergent Validity Outputs

### `convergent_validity_results.csv`
**Generated by:** `scripts/convergent_validity_ncv.py`
**Description:** Spearman correlations between within-sample CV and nCV-weighted score (Wu & Hogenesch method) across six TCGA cohorts.
**Rows:** 6 (one per cohort)
**Key columns:** cohort, rho, p_value
**Manuscript reference:** Methods (convergent validity paragraph)

### `thorsson_benchmarking_results.csv`
**Generated by:** `scripts/thorsson_benchmarking.py`
**Description:** Three sets of results: (1) CV-PD-L1 correlations within Thorsson immune subtypes, (2) incremental delta-R-squared beyond immune subtype, (3) CCD-based PD-L1 correlations.
**Manuscript reference:** Results 3.12

---

## Additional Outputs

### `hypothesis1_correlations.csv`
**Generated by:** Primary analysis scripts
**Description:** Detailed correlation results for the discovery cohorts (SKCM, LUAD).

### `evidence_ledger_prespecified.csv`
**Description:** Complete pre-specified endpoint audit listing all 32 endpoints with their FDR category (FDR-significant, Nominal, Non-significant). This is the source for the Evidence Summary Table in the manuscript.
**Rows:** 32
**Manuscript reference:** Evidence Summary Table
